Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Pharmacogenetics and Genomics
|
December 17, 2011
Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer
Liang Li, Daniel J Schaid, Brooke L Fridley, et al.
Molecular Psychiatry
|
October 27, 2022
Single cell transcriptomics reveals distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with opioid use disorder
Ming-Fen Ho, Cheng Zhang, Irene Moon, et al.
Pharmacogenetics and Genomics
|
January 18, 2013
FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder
Katarzyna A Ellsworth, Irene Moon, Bruce W Eckloff, et al.
Frontiers in Pharmacology
|
September 19, 2022
Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder
Ming-Fen Ho, Cheng Zhang, Irene Moon, et al.
British Journal of Pharmacology
|
January 11, 2022
Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study
Ming-Fen Ho, Cheng Zhang, Lixuan Wei, et al.
Molecular Metabolism
|
June 25, 2022
Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: Molecular links between the SNHG16 locus and catecholamine metabolism
Ming-Fen Ho, Cheng Zhang, Irene Moon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 19, 2012
Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlation
Yuan Ji, Kendra K S Nordgren, Yubo Chai, et al.
Brain, Behavior, and Immunity
|
June 9, 2024
IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study
Ming-Fen Ho, Cheng Zhang, James S Cohan, et al.
Cancer Research
|
January 6, 2010
Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors
Liewei Wang, Katarzyna A Ellsworth, Irene Moon, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2025
Alcohol Use Disorder Associated Gene <i>FNDC4</i> Alters Glutamatergic and GABAergic Neurogenesis
Xiujuan Zhu, August J John, Li Wang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Pharmacogenetics and Genomics
|
December 17, 2011
Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer
Liang Li, Daniel J Schaid, Brooke L Fridley, et al.
Molecular Psychiatry
|
October 27, 2022
Single cell transcriptomics reveals distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with opioid use disorder
Ming-Fen Ho, Cheng Zhang, Irene Moon, et al.
Pharmacogenetics and Genomics
|
January 18, 2013
FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder
Katarzyna A Ellsworth, Irene Moon, Bruce W Eckloff, et al.
Frontiers in Pharmacology
|
September 19, 2022
Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder
Ming-Fen Ho, Cheng Zhang, Irene Moon, et al.
British Journal of Pharmacology
|
January 11, 2022
Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study
Ming-Fen Ho, Cheng Zhang, Lixuan Wei, et al.
Molecular Metabolism
|
June 25, 2022
Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: Molecular links between the SNHG16 locus and catecholamine metabolism
Ming-Fen Ho, Cheng Zhang, Irene Moon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 19, 2012
Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlation
Yuan Ji, Kendra K S Nordgren, Yubo Chai, et al.
Brain, Behavior, and Immunity
|
June 9, 2024
IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study
Ming-Fen Ho, Cheng Zhang, James S Cohan, et al.
Cancer Research
|
January 6, 2010
Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors
Liewei Wang, Katarzyna A Ellsworth, Irene Moon, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2025
Alcohol Use Disorder Associated Gene <i>FNDC4</i> Alters Glutamatergic and GABAergic Neurogenesis
Xiujuan Zhu, August J John, Li Wang, et al.
Page
of 5